Mesenchymal stem cells and management of COVID-19 pneumonia.

Medicine in Drug Discovery(2020)

引用 130|浏览5
暂无评分
摘要
Human coronavirus, hCoV-19, is highly pathogenic with severe pneumonia associated with rapid virus replication. Arising in Wuhan China December 2019, the current COVID-19 epidemic has rapidly grown with person-to-person infection expanding to become a global health emergency now on pandemic scale.
更多
查看译文
关键词
Corona virus,Cytokine storm,Mesenchymal stem cells,Leukaemia inhibitory factor,Synthetic stem cells
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要